504A Stock Chart & Stats
$544.00
-$2.00(-0.37%)
―
--
Day’s Range― - ―
52-Week Range$377.00 - $1,248.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)78.99K
Market Cap
¥24.56B
Enterprise Value$9.78B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.45
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15.18
Shares Outstanding45,152,145
10 Day Avg. Volume87,960
30 Day Avg. Volume78,986
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Innovacell Inc. News
504A FAQ
What was Innovacell Inc.’s price range in the past 12 months?
Innovacell Inc. lowest stock price was $377.00 and its highest was $1248.00 in the past 12 months.
What is Innovacell Inc.’s market cap?
Innovacell Inc.’s market cap is ¥24.56B.
When is Innovacell Inc.’s upcoming earnings report date?
Innovacell Inc.’s upcoming earnings report date is Nov 11, 2026 which is in 29 days.
How were Innovacell Inc.’s earnings last quarter?
Innovacell Inc. released its earnings results on Aug 06, 2026. The company reported -$15.178 earnings per share for the quarter.
Is Innovacell Inc. overvalued?
According to Wall Street analysts Innovacell Inc.’s price is currently Undervalued.
Does Innovacell Inc. pay dividends?
Innovacell Inc. does not currently pay dividends.
What is Innovacell Inc.’s EPS estimate?
Innovacell Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innovacell Inc. have?
Innovacell Inc. has 45,152,145 shares outstanding.
What happened to Innovacell Inc.’s price movement after its last earnings report?
Innovacell Inc. reported an EPS of -$15.178 in its last earnings report. Following the earnings report the stock price went down -0.926%.
Which hedge fund is a major shareholder of Innovacell Inc.?
Currently, no hedge funds are holding shares in JP:504A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Innovacell Inc.
Innovacell Inc. is a biotech company that develops, manufactures, and sells cell therapy and regenerative medicine products aimed at treating fecal and urinary incontinence. The company's pipeline includes treatments for urgent fecal incontinence, leaky fecal incontinence, and stress urinary incontinence using the patient's own cells.
Technical Analysis
CellSource Co., Ltd.
―
Cyfuse Biomedical K.K.
―
StemCell Institute
―
Japan Tissue Engineering Co., Ltd.
―
CellSeed Inc.
―